Discover how India's PLI scheme for bulk drugs strengthens domestic API production, reduces import dependence, and enhances drug supply chain resilience for b
Learn about India's PLI scheme for pharma sector, ₹15,000 crore allocation, ₹6,659 crore disbursed, challenges in bulk drug production, and exam-relevant insi

